Immunomodulators targeting the PD-1/PD-L1 protein-protein interaction: From antibodies to small molecules
Author:
Affiliation:
1. Department of Medicinal Chemistry; Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey; Piscataway New Jersey
2. Cancer Pharmacology Program, Rutgers Cancer Institute of New Jersey; New Brunswick New Jersey
Publisher
Wiley
Subject
Drug Discovery,Pharmacology,Molecular Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/med.21530/fullpdf
Reference195 articles.
1. Cancer immunotherapy: historical perspective of a clinical revolution and emerging preclinical animal models;Decker;Front Immunol,2017
2. Metastatic melanoma: insights into the evolution of the treatments and future challenges;Millet;Med Res Rev,2017
3. Improved survival with vemurafenib in melanoma with BRAF V600E mutation;Chapman;N Engl J Med,2011
4. Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib;Sosman;N Engl J Med,2012
5. Cancer immunotherapy;Couzin-Frankel;Science,2013
Cited by 120 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Designing Peptide-Based Nanoinhibitors of Programmed Cell Death Ligand 1 (PD-L1) for Enhanced Chemo-immunotherapy;ACS Nano;2024-01-02
2. Emerging Immunotherapy Approaches for Advanced Clear Cell Renal Cell Carcinoma;Cells;2023-12-22
3. Balancing the Nanoscale Organization in Multivalent Materials for Functional Inhibition of the Programmed Death-1 Immune Checkpoint;ACS Nano;2023-12-21
4. Solubilizer Tag Effect on PD-L1/Inhibitor Binding Properties for m-Terphenyl Derivatives;ACS Medicinal Chemistry Letters;2023-12-14
5. PD-1 and PD-L1: architects of immune symphony and immunotherapy breakthroughs in cancer treatment;Frontiers in Immunology;2023-12-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3